Max Moldovan

Max Moldovan

Auto-generated profile, based on publicly available information

Max Moldovan

South Australian Health and Medical Research Institute, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2009 in Nature Genetics
Verified
Journal Article
Closed access
VSVijayaprakash Suppiah
Vijayaprakash Suppiah
MMMax Moldovan
Max Moldovan
GAGolo Ahlenstiel
Golo Ahlenstiel
TBTHOMAS BERG
THOMAS BERG
MWMartin Weltman
Martin Weltman
JGJacob George
Jacob George

20 July 2020 in eLife
Verified
Journal Article
Open access
ZNZeyad Nassar
Zeyad Nassar
CMChui Yan Mah
Chui Yan Mah
JDJonas Dehairs
Jonas Dehairs
IBIngrid Burvenich
Ingrid Burvenich
SISwati Irani
Swati Irani
LBLisa M. Butler
Lisa M. Butler
Fatty acid β-oxidation (FAO) is the main bioenergetic pathway in human prostate cancer (PCa) and a promising novel therapeutic vulnerability. Here we demonstrate therapeutic efficacy of targeting FAO in clinical prostate tumors cultured ex vivo, and identify DECR1, encoding the rate-limiting enzyme for oxidation of polyunsaturated fatty acids (PUFAs), as robustly overexpressed in PCa tissues and associated with shorter relapse-free survival. DECR1 is a negatively-regulated androgen receptor (AR) target gene and, therefore, may promote PCa cell survival and resistance to AR targeting therapeutics. DECR1 knockdown selectively inhibited β-oxidation of PUFAs, inhibited proliferation and migration of PCa cells, including treatment resistant lines, and suppressed tumor cell proliferation and metastasis in mouse xenograft models. Mechanistically, targeting of DECR1 caused cellular accumulation of PUFAs, enhanced mitochondrial oxidative stress and lipid peroxidation, and induced ferroptosis. These findings implicate PUFA oxidation via DECR1 as an unexplored facet of FAO that promotes survival of PCa cells.

4 October 2012 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
RHReece Hinchcliff
Reece Hinchcliff
DGDavid Greenfield
David Greenfield
MMMax Moldovan
Max Moldovan
JWJohanna Irene Westbrook
Johanna Irene Westbrook
MPMarjorie Pawsey
Marjorie Pawsey
JBJeffrey Braithwaite
Jeffrey Braithwaite
Aims To systematically identify and synthesise health service accreditation literature. Methods A systematic identification and narrative synthesis of health service accreditation literature published prior to 2012 were conducted. The search identified 122 empirical studies that examined either the processes or impacts of accreditation programmes. Study components were recorded, including: dates of publication; research settings; levels of study evidence and quality using established rating frameworks; and key results. A content analysis was conducted to determine the frequency of key themes and subthemes examined in the literature and identify knowledge-gaps requiring research attention. Results The majority of studies (n=67) were published since 2006, occurred in the USA (n=60) and focused on acute care (n=79). Two thematic categories, that is, ‘organisational impacts’ and ‘relationship to quality measures’, were addressed 60 or more times in the literature. ‘Financial impacts’, ‘consumer or patient satisfaction’ and ‘survey and surveyor issues’ were each examined fewer than 15 times. The literature is limited in terms of the level of evidence and quality of studies, but highlights potential relationships among accreditation programmes, high quality organisational processes and safe clinical care. Conclusions Due to the limitations of the literature, it is not prudent to make strong claims about the effectiveness of health service accreditation. Nonetheless, several critical issues and knowledge-gaps were identified that may help stimulate and inform discussion among healthcare stakeholders. Ongoing effort is required to build upon the accreditation evidence-base by using high quality experimental study designs to examine the processes, effectiveness and financial value of accreditation programmes and their critical components in different healthcare domains.

20 September 2012 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
DGDavid Greenfield
David Greenfield
MPMarjorie Pawsey
Marjorie Pawsey
RHReece Hinchcliff
Reece Hinchcliff
MMMax Moldovan
Max Moldovan
JBJeffrey Braithwaite
Jeffrey Braithwaite
Healthcare accreditation standards are advocated as an important means of improving clinical practice and organisational performance. Standard development agencies have documented methodologies to promote open, transparent, inclusive development processes where standards are developed by members. They assert that their methodologies are effective and efficient at producing standards appropriate for the health industry. However, the evidence to support these claims requires scrutiny. The study’s purpose was to examine the empirical research that grounds the development methods and application of healthcare accreditation standards.

6 August 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
LBLisa M. Butler
Lisa M. Butler
CMChui Yan Mah
Chui Yan Mah
JMJelle Machiels
Jelle Machiels
AVAndrew D. Vincent
Andrew D. Vincent
SISwati Irani
Swati Irani
JSJohannes Victor Swinnen
Johannes Victor Swinnen
Dysregulated lipid metabolism is a prominent feature of prostate cancer that is driven by androgen receptor (AR) signaling. Here we used quantitative mass spectrometry to define the “lipidome” in prostate tumors with matched benign tissues (n = 21), independent unmatched tissues (n = 47), and primary prostate explants cultured with the clinical AR antagonist enzalutamide (n = 43). Significant differences in lipid composition were detected and spatially visualized in tumors compared with matched benign samples. Notably, tumors featured higher proportions of monounsaturated lipids overall and elongated fatty acid chains in phosphatidylinositol and phosphatidylserine lipids. Significant associations between lipid profile and malignancy were validated in unmatched samples, and phospholipid composition was characteristically altered in patient tissues that responded to AR inhibition. Importantly, targeting tumor-related lipid features via inhibition of acetyl-CoA carboxylase 1 significantly reduced cellular proliferation and induced apoptosis in tissue explants. This characterization of the prostate cancer lipidome in clinical tissues reveals enhanced fatty acid synthesis, elongation, and desaturation as tumor-defining features, with potential for therapeutic targeting. Significance: This study identifies malignancy and treatment-associated changes in lipid composition of clinical prostate cancer tissues, suggesting that mediators of these lipidomic changes could be targeted using existing metabolic agents.

13 February 2013 in International Journal for Quality in Health Care
Verified
Journal Article
Open access
PDF file
CSCharles D. Shaw
Charles D. Shaw
JBJeffrey Braithwaite
Jeffrey Braithwaite
MMMax Moldovan
Max Moldovan
WNWendy Nicklin
Wendy Nicklin
IGIleana Grgic
Ileana Grgic
SWStuart Whittaker
Stuart Whittaker
To describe global patterns among health-care accreditation organizations (AOs) and to identify determinants of sustainability and opportunities for improvement. Web-based questionnaire survey. Organizations offering accreditation services nationally or internationally to health-care provider institutions or networks at primary, secondary or tertiary level in 2010. External relationships, scope and activity public information. Forty-four AOs submitted data, compared with 33 in a survey 10 years earlier. Of the 30 AOs that reported survey activity in 2000 and 2010, 16 are still active and stable or growing. New and old programmes are increasingly linked to public funding and regulation. While the number of health-care AOs continues to grow, many fail to thrive. Successful organizations tend to complement mechanisms of regulation, health-care funding or governmental commitment to quality and health-care improvement that offer a supportive environment. Principal challenges include unstable business (e.g. limited market, low uptake) and unstable politics. Many organizations make only limited information available to patients and the public about standards, procedures or results.